Share This Article:

Trk Family Neurotrophin Receptors and p75 Receptor. A Multiple Competing Hypothesis Case in the Nerve Growth Factor (NGF) History

Full-Text HTML Download Download as PDF (Size:523KB) PP. 93-103
DOI: 10.4236/ahs.2014.32009    3,194 Downloads   5,327 Views  


In the area of Trk oncogene, this research has revealed the different competing hypotheses made at the time of its discovery. A conflict of interest arose within the group who identified it as the nerve growth factor receptor (NGF). An auxiliary assumption, on the cardinal importance of the low affinity p75 receptor, resulted in that the consistency of the group take patterns of competence. The level of provocation affected the joint effort. An environment reminds the denial that Stehelin was given by Varmus and Bishop, in the race for the Nobel Prize in Physiology or Medicine. Nowadays p75 receptor functions are described as “enigmatic”, and accepted that all the neurotrophins interact with two types of receptors: the specific to the ligands of the high-affinity Trk family of receptors and the low affinity p75 receptor (with structural similarities to the tumor necrosis factor and in liaison with the development of eye optical fiber). Against this background, papers concerning this subject and included in the ISI citation database are analysed, categorizing them through a system of descriptors, according to their original publication date. Complete time vectors are approximated by setting the analysis with a growth model based on Gompertz function. After the criteria used by authorities like Rita Levi-Montalcini, Luigi Cavalli-Sforza, Rodolfo Llinás and Victor McKunsick the selected material resulted in a database with 371 records. The data suggest the opportunity for historical sciences of a non-discrimination compliance test performed on multiple hypotheses.

Cite this paper

Barreiro, E. (2014). Trk Family Neurotrophin Receptors and p75 Receptor. A Multiple Competing Hypothesis Case in the Nerve Growth Factor (NGF) History. Advances in Historical Studies, 3, 93-103. doi: 10.4236/ahs.2014.32009.


[1] Akanuma, A. (1978). Parameter Analysis of Gompertzian Function Growth Model in Clinical Tumors. European Journal of Cancer, 14, 681-688.
[2] Barbacid, M. (1993). Nerve Growth Factor: A Tale of Two Receptors. Oncogene, 8, 2033-2042.
[3] Barker, P. A. (2004). P75NTR Is Positively Promiscuous: Novel Partners and New Insights. Neuron, 42, 529-533.
[4] Brozek, V., & Karen, P. (1979). Dynamics of Information Flow in the Field of Rare Earth Carbides Research. Scientometrics, 1, 339-357.
[5] Cherfas, J. (1994). Does Trk Protein Act Alone, Or Is It a Conspiracy? Current Contents, 22, 3-5.
[6] Cleland, C. E. (2001). Historical Science, Experimental Science, and the Scientific Method. Geology, 29, 987-990.<0987:HSESAT>2.0.CO;2
[7] Conover, W. J. (1980). Practical Non-parametric Statistics (2nd ed.). New York: Wiley.
[8] Cuadros, M. A., Coltey, P., Nieto, Ma. C., & Martin, C. (1992). Demonstration of Phagocytic Cell System Belonging to the Hemopoietic Lineage and Originating from the Yolk sac in the Early Avian Embryo. Development, 115, 157-168.
[9] Egghe, L., & Rousseau, R. (1990). Introduction to Informetrics. Amsterdam: Elsevier.
[10] Ehrhard, P. B., Erb, P., Graumann, U., & Otten, U. (1993). Expression of Nerve Growth Factor and Nerve Growth Factor Receptor Tyrosine Kinase Trk in Activated CD4-Positive T-Cell Clones. Proceedings of National Academy of Sciences USA, 90, 10984-10988.
[11] Frade, J. Ma., Rodríguez-Tebar, A., & Barde, Y.-A. (1996). Induction of Cell Death by Endogenous Nerve Growth Factor through Its p75 Receptor. Nature, 383, 166-168.
[12] Garfield, E., Pudovkin, A. I., & Istomin, V. S. (2003). Why Do We Need Algorithmic Historiography? Journal of the American Society for Information Science and Technology (JASIST), 54, 400-412.
[13] Grimes, M. L., Beattie, E., & Mobley, W. C. (1997). A Signaling Organelle Containing the Nerve Growth Factor-Activated Receptor Tyrosine Kinase, TrkA. Proceedings of National Academy of Sciences USA, 94, 9909-9914.
[14] He, X.-L., & Farcía, C. (2004). Structure of Nerve Growth Factor Complexed with the Shared Neurotrophin Receptor p75. Science, 304, 870-875.
[15] Krimsky, S. (2002). Who Owns Academic Work? Battling for Control of Intellectual Property. By Corynne McSherry. Harvard University Press, 2001. Nature Medicine, 8, 325.
[16] Laudan, R., Laudan, L., & Donovan, A. (1988). Testing Theories of Scientific Change. In A. Donovan, L. Laudan, & R. Laudan (Eds.), Scrutinizing Science: Empirical Studies of Scientific Change (pp. 3-44). Dordrecht [etc.]: Kluwer.
[17] Levin, S. G., & Stephan, P. E. (1999). Sociology of Science—Are the Foreign Born a Source of Strength for U.S. Science? Science, 285, 1213-1214.
[18] López Piñero, J. M.a, & Terrada, Ma L. (1993). Veinte años de investigación bibliométrica en el Instituto de Estudios Documentales e Históricos sobre la Ciencia. Valencia: Universidad, CSIC.
[19] Meakin, S. O., & Shooter, E. M. (1991). Tyrosine Kinase Activity Coupled to the High-Affinity Nerve Growth Factor-Receptor Complex. Proceedings of National Academy of Sciences USA, 88, 5862-5866.
[20] Merton, R. K. (1963). Resistance to the Systematic Study of Multiple Discoveries in Science. European Journal of Sociology, 4, 237-249.
[21] Mutoh, T., Tokuda, A., Miyadai, T., Hamaguchi, M., & Fujiki, N. (1995). Ganglioside GM1 Binds to the Trk Protein and Regulates Receptor Function. Proceedings of National Academy of Sciences USA, 92, 5087-5091.
[22] Pellicer, A. (2004). Contribución de los científicos españoles en Estados Unidos a la bioquímica. In E. Muñoz (Ed.), Cuarenta años de la Sociedad Española de Bioquímica y Biología Molecular (1963-2003) (pp. 227-248). Madrid: SECC.
[23] Scherer, F. M. (2000). The Emigration of German-Speaking Economists after 1933. Journal of Economic Literature, XXXVIII, 614-626.
[24] Shapin, S., & Thackray, A. (1974). Prosopography as a Research Tool in History of Science: The British Scientific Community 1700-1900. History of Science, 12, 1-28.
[25] Siegel, G. J. (1999). Basic Neurochemistry: Molecular, Cellular and Medical Aspects (6th ed.). Philadelphia, Lippincott: Williams & Wilkins.
[26] Tessarollo, L., Tsoulfas, P., Donovan, M. J., Palko, M. E., Blair-Flynn, J., Hempstead, B. L., & Parada, L. F. (1997). Targeted Deletion of All Isoforms of the trkC Gene Suggests the Use of Alternate Receptors by Its Ligand Neurotrophin-3 in Neuronal Development and Implicates trkC in Normal Cardiogenesis. Proceedings of National Academy of Sciences USA, 94, 14776-14781.
[27] Vecino, E. (1998). Las neurotrofinas y su uso en la clínica. Archivos de la Sociedad Española de Oftalmología, 11.
[28] Wulff Barreiro, E. (1996). History of the Discovery of the Origins of the Tumor Formation: Dr. Barbacid’s Program at the Beginning of the Research on Oncogenes. Llull, 19, 525-550.

comments powered by Disqus

Copyright © 2017 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.